Category

• Pipeline3
• Research1

Organizations

• Bausch + Lomb47
• Eyes On Eyecare34
• American Optometric Association26
• Alcon, Inc.23
• Glaukos20
• Harrow20
• Aldeyra Therapeutics16
• Ocuphire Pharma16
• Sight Sciences16
• American Academy Of Ophthalmology15

Tags

• Glaucoma3
• Clinical Trials2
• Lasers2
• Products2
• IOP1
• Ophthalmic Tech1
• Tech1

• organizations:ViaLase✕

Clear all

Research

ViaLase and Moran Eye Center launch glaucoma research partnership

Collaboration combines ViaLase’s novel femtosecond laser procedure with iPerfusion technology to better understand the IOP-lowering effect.

Pipeline

Enrollment concludes for ViaLase's pivotal POAG laser trial

First femtosecond laser image-guided high-precision trabeculectomy (FLigHT) offers the potential as a non-invasive treatment.

Pipeline

ViaLase reports 24-month data on first-in-human study for FLigHT

Follow-up results indicate a new potential for IOP reduction in glaucoma treatment.

Pipeline

Positive results reported for first-in-human study of FLigHT for POAG

ViaLase technology used in trial for femtosecond laser image-guided high-precision trabeculectomy.